Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
Clinical trial NCT03540043 · COMPLETED
Trial details
- NCT number
- NCT03540043
- Sponsor
- PurGenesis Technologies Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2019-12-31
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.